CELL-EASY Revenue and Competitors
Estimated Revenue & Valuation
- CELL-EASY's estimated annual revenue is currently $6.2M per year.
- CELL-EASY's estimated revenue per employee is $155,000
Employee Data
- CELL-EASY has 40 Employees.
- CELL-EASY grew their employee count by 5% last year.
CELL-EASY's People
| Name | Title | Email/Phone |
|---|
CELL-EASY Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is CELL-EASY?
Cell-Easy is a cell therapy Contract Development and Manufacturing Organization (CDMO) for preclinical and clinical drug development projects. Cell-Easy's aspiration is to dramatically reduce stem cell manufacturing cost, starting with ASC (historical and local strong expertise), to change the affordability challenge currently met by Cell Therapies. Our ASC production process was designed using QbD approach and economical study (Manufacturing Cost model simulation) to ensure cell quality, scalability, compatibility with GMP requirements and economic viability for the entire clinical development INCLUDING the commercialization. Cell-Easy is a recent and fast-growing biotech start up based in Toulouse, France.
keywords:N/A
N/A
Total Funding
40
Number of Employees
$6.2M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CELL-EASY News
You can effortlessly url your cell cellular phone to your Laptop working with a QR code. Smartphone Link can do that. Obtain: smartphone link...
Catalent has acquired a commercial-scale cell therapy manufacturing ... It is located within easy reach of Catalent's facilities around...
... our chemical reprogramming represents a safer and easy-to-standardized way of making human stem cells for clinical delivery, Deng said.
Other Companies in Toulouse
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.8M | 40 | 8% | N/A |
#2 | $5.1M | 40 | -2% | N/A |
#3 | $7M | 40 | 48% | N/A |
#4 | $4.3M | 41 | 41% | N/A |
#5 | $4.8M | 41 | 32% | N/A |